Mint Neurotechnologies secures £1m seed funding led by Empirical Ventures
The capital injection will accelerate the silicon roadmap for minimally invasive neural implant applications.
Mint Neurotechnologies develops low-power semiconductor technology to enable smaller and more scalable neural implants. The company originates from research at Imperial College London.
Mint Neurotechnologies has secured £1m in seed funding to accelerate its silicon roadmap and advance neural implant devices. The investment round was led by Empirical Ventures, with participation from Parkwalk Advisors, Imperial College London, Plug & Play, Excellis Holding, and several angel investors. The capital will support the delivery of next-generation medical technologies aimed at addressing neurological conditions.
From the founder
"Our semiconductor-based approach is fundamentally reshaping what neural implants can achieve. By offering a customisable, compact solution that integrates seamlessly into medical devices, we’re empowering a new era of neural interfaces that are not only more powerful but also less invasive. This marks a transformative shift in neurological care."
Timothy Constandinou
CTO and co-founder at Mint Neurotechnologies
Investor perspective
"MintNeuro is uniquely addressing the core limitations of neural implants with a semiconductor-based approach. We are excited about the market opportunity and the potential of entrepreneurial scientists like Dorian and Tim to drive forward the next generation of neural implants."
Johnathan Matlock
Empirical Ventures
Use of funds
- 01Continue product development
- 02Grow the team
Investors
Johnathan Matlock
Empirical Ventures
Martin Glen
Parkwalk Advisors
Imperial College London
Plug & Play
Excellis Holding
Categories
About the company
Mint Neurotechnologies
Semiconductor developer creating scalable and low-power neural implants.